Cargando…

Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation

BACKGROUND: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wei, Zhao, Kang-Mei, Luo, Li-Hui, Yu, Yang, Zhu, Sheng-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830827/
https://www.ncbi.nlm.nih.gov/pubmed/29451147
http://dx.doi.org/10.4103/0366-6999.225049
_version_ 1783303072644071424
author Zheng, Wei
Zhao, Kang-Mei
Luo, Li-Hui
Yu, Yang
Zhu, Sheng-Mei
author_facet Zheng, Wei
Zhao, Kang-Mei
Luo, Li-Hui
Yu, Yang
Zhu, Sheng-Mei
author_sort Zheng, Wei
collection PubMed
description BACKGROUND: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. METHODS: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. RESULTS: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. CONCLUSIONS: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes.
format Online
Article
Text
id pubmed-5830827
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58308272018-03-07 Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation Zheng, Wei Zhao, Kang-Mei Luo, Li-Hui Yu, Yang Zhu, Sheng-Mei Chin Med J (Engl) Original Article BACKGROUND: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. METHODS: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. RESULTS: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. CONCLUSIONS: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes. Medknow Publications & Media Pvt Ltd 2018-02-20 /pmc/articles/PMC5830827/ /pubmed/29451147 http://dx.doi.org/10.4103/0366-6999.225049 Text en Copyright: © 2018 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Zheng, Wei
Zhao, Kang-Mei
Luo, Li-Hui
Yu, Yang
Zhu, Sheng-Mei
Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_full Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_fullStr Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_full_unstemmed Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_short Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_sort perioperative single-donor platelet apheresis and red blood cell transfusion impact on 90-day and overall survival in living donor liver transplantation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830827/
https://www.ncbi.nlm.nih.gov/pubmed/29451147
http://dx.doi.org/10.4103/0366-6999.225049
work_keys_str_mv AT zhengwei perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT zhaokangmei perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT luolihui perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT yuyang perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT zhushengmei perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation